Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Deciding between cash back and rewards credit cards? This guide helps you compare features to find the best option for your financial goals.
26,399 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Insider moves can ripple through biotech stocks. This piece breaks down recent tarsus pharma stock insider activity, ...
Movement Mortgage’s reverse mortgage division is pursuing modest growth through organic leads and purpose-driven lead...
Nvidia has acquired Kumo AI, adding enterprise-focused foundation models to its AI stack. Founders join Nvidia, with ...
More than 40 analysts now rate AMD a Buy as AI-driven data center demand fuels growth. Here’s why the stock could pus...
VOO remains the default way to own the market, but cheaper S&P 500 ETFs challenge the long-held view. The difference ...
On Thursday, Vertex stock surged nearly 6% after a positive analyst note. This guide breaks down what drove the move,...
CrowdStrike delivered a solid ARR beat but guided below lofty expectations, triggering a about 7% drop in CRWD shares...
State Farm is rolling out an AI-driven claims platform as part of a broader push to reinvent pricing and service. The...
Stocks drift with a quiet S&P 500 backdrop while volatility concentrates in single stocks. The market faces asymmetri...
On a midweek Tuesday when tech stocks sagged, Salesforce bucked the trend. A fresh bullish note from a respected anal...
Jim Cramer argues that the MAG 7 must be analyzed separately, not as a single basket, outlining five core reasons eac...